{"url_path":"/sec/imux/8-k/2026-09-11/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-09-11","source_url":"https://www.sec.gov/Archives/edgar/data/1280776/0001193805-26-001219-index.html","accession_number":"0001193805-26-001219","cik":"0001280776","ticker":"IMUX","issuer_name":"IMMUNIC, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1280776/0001193805-26-001219-index.html","primary_entity_key":"0001280776","primary_entity_name":"IMMUNIC, INC."},"word_count":74,"has_tables":true,"body_markdown":"**Item 9.01. Financial Statements and Exhibits.**\n\n \n\n**Exhibit Number**\n**Description**\n\n104\nCover Page Interactive Data File-the cover page XBRL tags are embedded within the Inline XBRL document.\n\n \n\n \n\n \n\n \n\n**SIGNATURES**\n\n** **\n\nPursuant to the requirements of the Securities Exchange Act of 1934,\nas amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.\n\n \n\nDated: September 11, 2026\n**Immunic, Inc.**\n\n \n \n \n\n \nBy:\n*/s/ Erik Lundgren*\n\n \n \nErik Lundgren\n\n \n \nChief Executive Officer"}